Table 3.
Group A (light grey) versus group B (dark grey) | NTRK1 | NTRK2 | NTRK3 | NGFR | EGFR | PDGFRA | Wnt7B | |
---|---|---|---|---|---|---|---|---|
CNS BCOR‐ITD, n = 8 | BCOR‐ITD sarcomas, n = 15 | n/s | 28.0 | n/s | n/s | n/s | n/s | 15.8 |
CNS BCOR‐ITD, n = 8 | Ependymomas, n = 10 | n/s | 5.7 | 7.3 | 24.9 | 4.0 | 22.2 | 14.0 |
CNS BCOR‐ITD, n = 8 | Medulloblastomas, n = 21 | n/s | 33.0 | 1.8 | 26.4 | 9.4 | 13.1 | 39.1 |
BCOR‐ITD sarcomas, n = 15 | Ewing sarcomas, n = 30 | −1.6 | 2.2 | 29.4 | 5.6 | 12.7 | 28.8 | 2.4 |
The fold‐change of expression of seven genes between tumours of group A (light grey) and tumours of group B (dark grey) is presented. The number of cases in each group is indicated. Fold‐change is shown in favour of the tumours of group A (light grey). Values shown in bold are considered of high significance.